首页> 外文期刊>Metabolic syndrome and related disorders >Prevalence of Prediabetes Based on Fasting Plasma Glucose and Glycosylated Hemoglobin in an At-Risk Mexican Population
【24h】

Prevalence of Prediabetes Based on Fasting Plasma Glucose and Glycosylated Hemoglobin in an At-Risk Mexican Population

机译:在空腹的墨西哥人群中,基于空腹血浆葡萄糖和糖基化血红蛋白的糖尿病前期患病率

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In Latin America, there are no published studies of the prevalence of prediabetes using the glycosylated hemoglobin (HbA1c) criterion in addition to fasting plasma glucose (FPG). Therefore, here we determined the prevalence of prediabetes using FPG and/or HbA1c in a Mexican population at risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease. Methods: This cross-sectional study included 384 primary care users without a known diagnosis of prediabetes or T2DM and with at least one risk factor for T2DM and cardiovascular disease. An FPG 100-125 mg/dL and/or an HbA1c 5.7-6.4% were considered positive for prediabetes. Point prevalence and 95% confidence intervals (CI) were estimated overall and stratified by age, sex, and nutritional status. Mann-Whitney and chi-squared tests were used. P values < 0.05 were considered significant. Results: The prevalence of prediabetes was 74.7% (95% CI, 70.2%-78.8%) using FPG or HbA1c criteria for positivity, 60.4% using FPG alone (95% CI, 55.5%-65.3%), 49.8% using HbA1c alone (95% CI, 44.4-55.3%); and 32.9% using FPG and HbA1c (95% CI, 27.8%-38.0%). Prevalence was higher in patients >= 50 years old (p < 0.001) and in the overweight-obesity group (p = 0.04) using all criteria except for HbA1c alone. Conclusions: The prevalence of prediabetes in a Mexican population at risk for cardiovascular disease and/or T2DM was high. Prediabetes is definitely a public health problem. Future studies are needed to examine the effectiveness and efficiency of pragmatic strategies to reverse the status of prediabetes and, therefore, reduce the incidence of T2DM.
机译:背景:在拉丁美洲,除了空腹血糖(FPG)之外,还没有使用糖基化血红蛋白(HbA1c)标准对糖尿病前期患病率进行发表的研究。因此,在这里我们确定了使用FPG和/或HbA1c在患有2型糖尿病(T2DM)和心血管疾病风险的墨西哥人群中的前驱糖尿病患病率。方法:这项横断面研究包括384名初级保健使用者,他们没有已知的糖尿病前期或T2DM诊断,并且至少有一个T2DM和心血管疾病的危险因素。 FPG 100-125 mg / dL和/或HbA1c 5.7-6.4%被认为是糖尿病前期阳性。总体估计了点患病率和95%置信区间(CI),并按年龄,性别和营养状况进行了分层。使用了Mann-Whitney和卡方检验。 P值<0.05被认为是显着的。结果:使用FPG或HbA1c阳性标准,前驱糖尿病的患病率为74.7%(95%CI,70.2%-78.8%),单独使用FPG的患病率为60.4%(95%CI,55.5%-65.3%),单独使用HbA1c的患病率为49.8%。 (95%CI,44.4-55.3%);使用FPG和HbA1c的比例为32.9%(95%CI,27.8%-38.0%)。使用单独的HbA1c以外的所有标准,≥50岁的患者(p <0.001)和超重肥胖组(p = 0.04)的患病率较高。结论:在有心血管疾病和/或T2DM风险的墨西哥人群中,前驱糖尿病的患病率很高。糖尿病前期绝对是一个公共卫生问题。需要进行进一步的研究来检验务实策略逆转糖尿病前期状况的有效性和效率,从而降低T2DM的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号